While some studies have reported an association between COX-2 levels and lymph node metastasis in NPC, others have found none, and COX-2’s diagnostic and prognostic values in NPC and the role of COX-2 inhibitors in treatment remain uncertain. The gene discussed is PTGS2; the disease is metastatic malignant neoplasm in the lymph nodes.